Recommended immunization schedule for children and adolescents: the Korean Pediatric Society, 2013

Dae Sun Jo1, Jong-Hyun Kim, Eun Hwa Choi

  • 1Department of Pediatrics, Chonbuk National University Medical School, Jeonju, Korea.

Insights

The Korean Pediatric Society updated its 2013 immunization schedule, including the Haemophilus influenzae type b vaccine in the National Immunization Program. This guide offers catch-up schedules for children and adolescents needing timely vaccinations.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • The Committee on Infectious Diseases of the Korean Pediatric Society provides essential immunization guidelines.
  • Previous guidelines were released in 2012.
  • The National Immunization Program in Korea has incorporated the Haemophilus influenzae type b vaccine.

Purpose of the Study:

  • To present the updated recommended immunization schedule for Korean children and adolescents as of March 2013.
  • To provide a catch-up immunization schedule for individuals who have not followed the recommended timeline.
  • To inform pediatricians about the latest vaccination guidelines.

Main Methods:

  • The article details the revised immunization schedules.
  • It incorporates the inclusion of the Haemophilus influenzae type b vaccine.
  • The schedules are a revision of the 2012 "Immunization Guideline, 7th edition."

Main Results:

  • The updated schedule includes the Haemophilus influenzae type b vaccine.
  • A catch-up schedule is provided for children and adolescents.
  • The guidelines reflect minor revisions from the 2012 edition.

Conclusions:

  • Pediatricians must be aware of the updated immunization schedules.
  • Adequate immunization is crucial for the health of Korean children and adolescents.
  • The updated schedule ensures alignment with national vaccination programs and public health recommendations.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Vaccinations01:51

Vaccinations

Overview
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...